Summary of Significant Accounting Policies (Details) - USD ($) $ in Thousands			6 Months Ended
	Jan. 01, 2023	Jan. 01, 2022	Jun. 30, 2023	Jun. 30, 2022	Mar. 31, 2023	Dec. 31, 2022		Mar. 31, 2022	Dec. 31, 2021
Financing Receivable, Impaired [Line Items]
Stockholders' equity attributable to parent			$ (2,526,772)	$ (2,718,396)	$ (2,579,123)	$ (2,471,790)		$ (3,008,392)	$ (3,406,352)
Deferred income tax (benefit) expense			(76,861)	14,824
Retained Earnings
Financing Receivable, Impaired [Line Items]
Stockholders' equity attributable to parent			$ (1,704,470)	$ (1,817,474)	$ (1,672,169)	(1,881,775)		$ (1,782,997)	(1,768,653)
Cumulative effect accounting adjustment
Financing Receivable, Impaired [Line Items]
Stockholders' equity attributable to parent						(822)	[1]		20,098	[2]
Deferred income tax (benefit) expense	$ 300	$ 7,900
Cumulative effect accounting adjustment | Retained Earnings
Financing Receivable, Impaired [Line Items]
Stockholders' equity attributable to parent						$ (822)	[1]		$ 20,098	[2]

[1] Represents gross transition adjustment amount of $1.1 million, net of taxes of $0.3 million, to reflect the cumulative impact on retained earnings pursuant to the Company’s adoption of Accounting Standards Update 2022-02. Refer to Note 4, “Loans and Allowance for Credit Losses” within the Notes to the Unaudited Consolidated Financial Statements included in Part I, Item 1 in this Quarterly Report on Form 10-Q for additional discussion.

[2] Represents gross transition adjustment amount of $28.0 million, net of taxes of $7.9 million, to reflect the cumulative impact on retained earnings pursuant to the Company’s adoption of Accounting Standards Update 2016-13. Refer to Note 4, “Loans and Allowance for Credit Losses” within the Notes to the Unaudited Consolidated Financial Statements included in Part I, Item 1 in this Quarterly Report on Form 10-Q for additional discussion.